OCTREOTIDE

OCTREOTIDE was reported 30706 times

OCTREOTIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS 11 0.8462
1 ANTI FACTOR V ANTIBODY 19 0.6786
2 ELECTROCARDIOGRAM T WAVE ALTERNANS 16 0.3721
3 CARCINOID CRISIS 60 0.2655
4 CARCINOID HEART DISEASE 19 0.2088
5 LACTOBACILLUS BACTERAEMIA 4 0.1905
6 INTESTINAL INTRAEPITHELIAL LYMPHOCYTES INCREASED 9 0.1343
7 SMALL INTESTINE NEUROENDOCRINE TUMOUR 7 0.1273
8 GASTRINOMA 8 0.1212
9 RADIAL PULSE DECREASED 4 0.1143
10 MICROVILLOUS INCLUSION DISEASE 8 0.1067
11 CARCINOID SYNDROME 36 0.0994
12 PROBIOTIC THERAPY 8 0.0808
13 PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC 17 0.0711
14 PANCREATIC NEUROENDOCRINE TUMOUR 45 0.0702
15 CRYPTITIS 9 0.0647
16 HYPERRESPONSIVE TO STIMULI 4 0.0635
17 INSULINOMA 11 0.0621
18 HYPEROXALURIA 10 0.0581
19 FACTOR V INHIBITION 9 0.0464
20 GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOUR DISEASE 5 0.0450
21 BLOOD CHROMOGRANIN A INCREASED 20 0.0436
22 NEUROENDOCRINE CARCINOMA METASTATIC 10 0.0407
23 BILE ACID MALABSORPTION 11 0.0390
24 METASTATIC CARCINOID TUMOUR 4 0.0385
25 BLOOD GROWTH HORMONE INCREASED 20 0.0358
26 APOPTOSIS 9 0.0291
27 ACROMEGALY 9 0.0284
28 SERUM SEROTONIN INCREASED 10 0.0282
29 DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY 6 0.0282
30 CERVIX CARCINOMA RECURRENT 5 0.0281
31 HYPERINSULINAEMIC HYPOGLYCAEMIA 6 0.0270
32 NEUROENDOCRINE TUMOUR 37 0.0261
33 HYPERDYNAMIC LEFT VENTRICLE 6 0.0244
34 CHYLOTHORAX 17 0.0236
35 TACHYPHYLAXIS 8 0.0229
36 CARCINOID TUMOUR 16 0.0215
37 BLOOD CORTICOTROPHIN INCREASED 6 0.0208
38 ADRENAL SUPPRESSION 17 0.0202
39 NECROTISING COLITIS 24 0.0189
40 INSULIN-LIKE GROWTH FACTOR INCREASED 27 0.0189
41 NEUROENDOCRINE CARCINOMA 12 0.0173
42 CARCINOID TUMOUR PULMONARY 4 0.0166
43 METASTASES TO GASTROINTESTINAL TRACT 4 0.0166
44 NECROTISING ENTEROCOLITIS NEONATAL 6 0.0148
45 CATARACT SUBCAPSULAR 9 0.0148
46 NECROTISING OESOPHAGITIS 7 0.0140
47 PLASMABLASTIC LYMPHOMA 5 0.0140
48 ANGIODYSPLASIA 5 0.0137
49 CRYSTAL NEPHROPATHY 8 0.0135
50 IDIOPATHIC PNEUMONIA SYNDROME 4 0.0134
51 EHLERS-DANLOS SYNDROME 6 0.0129
52 GASTROINTESTINAL STOMA OUTPUT INCREASED 6 0.0128
53 PRODUCT INEFFECTIVE 10 0.0127
54 GASTROINTESTINAL STOMA COMPLICATION 19 0.0121
55 METASTASES TO BREAST 4 0.0120
56 GASTRIC ANTRAL VASCULAR ECTASIA 6 0.0113
57 METASTASES TO PANCREAS 5 0.0113
58 EROSIVE DUODENITIS 9 0.0112
59 GLOMERULOSCLEROSIS 7 0.0111
60 ABDOMINAL WALL DISORDER 3 0.0103
61 NEPHRITIS ALLERGIC 4 0.0101
62 LYMPHATIC DISORDER 6 0.0101
63 TRICUSPID VALVE DISEASE 4 0.0100
64 TERMINAL ILEITIS 6 0.0098
65 SINUS ARREST 15 0.0096
66 INTESTINAL VILLI ATROPHY 4 0.0095
67 METASTASES TO PELVIS 6 0.0095
68 ROTAVIRUS INFECTION 5 0.0087
69 METASTASES TO ABDOMINAL CAVITY 4 0.0081
70 PITUITARY TUMOUR 12 0.0080
71 HYPOGLYCAEMIC SEIZURE 7 0.0077
72 FAECAL VOLUME INCREASED 4 0.0077
73 RECTAL ULCER 9 0.0077
74 ENCEPHALITIS AUTOIMMUNE 10 0.0076
75 BIOPSY 7 0.0076
76 PULMONARY VALVE INCOMPETENCE 11 0.0075
77 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 19 0.0071
78 THYROXINE FREE DECREASED 4 0.0071
79 CELL DEATH 14 0.0071
80 LABILE BLOOD PRESSURE 8 0.0067
81 CYTOGENETIC ANALYSIS ABNORMAL 7 0.0067
82 TUMOUR NECROSIS 7 0.0066
83 LIVER ABSCESS 21 0.0065
84 LIPOHYPERTROPHY 4 0.0064
85 HEPATIC NEOPLASM 21 0.0064
86 RIGHT VENTRICULAR DYSFUNCTION 7 0.0063
87 PANCREATIC FAILURE 11 0.0062
88 SHORT-BOWEL SYNDROME 4 0.0061
89 HYPOGONADISM 6 0.0059
90 STOMA COMPLICATION 6 0.0059
91 SEIZURE LIKE PHENOMENA 10 0.0059
92 HEPATIC CANCER METASTATIC 5 0.0058
93 METASTASES TO LIVER 102 0.0058
94 GASTROINTESTINAL NEOPLASM 5 0.0058
95 CUSHINGOID 18 0.0056
96 ABDOMINAL NEOPLASM 5 0.0056
97 GRAFT VERSUS HOST DISEASE IN LIVER 4 0.0056
98 HEPATIC LESION 24 0.0055
99 RADIOTHERAPY 10 0.0052
100 PAROTITIS 6 0.0052
101 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 4 0.0051
102 INTRA-ABDOMINAL HAEMORRHAGE 12 0.0050
103 IIIRD NERVE PARALYSIS 4 0.0049
104 METASTASES TO SKIN 5 0.0048
105 CAPILLARY LEAK SYNDROME 10 0.0048
106 SYSTOLIC DYSFUNCTION 5 0.0047
107 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 10 0.0047
108 OESOPHAGEAL VARICES HAEMORRHAGE 10 0.0046
109 PNEUMATOSIS INTESTINALIS 13 0.0046
110 CEREBRAL HAEMATOMA 15 0.0045
111 CANDIDA SEPSIS 4 0.0045
112 BLOOD PRESSURE SYSTOLIC INCREASED 87 0.0045
113 SKIN NECROSIS 23 0.0044
114 FAECAL CALPROTECTIN INCREASED 14 0.0044
115 SHOCK HAEMORRHAGIC 35 0.0043
116 BRASH SYNDROME 6 0.0043
117 VASOPLEGIA SYNDROME 7 0.0043
118 INTUSSUSCEPTION 4 0.0042
119 PERFORMANCE STATUS DECREASED 19 0.0041
120 HEMIANOPIA 4 0.0040
121 RUBBER SENSITIVITY 6 0.0039
122 BODY TEMPERATURE DECREASED 38 0.0039
123 TUMOUR PAIN 5 0.0038
124 PNEUMOPERITONEUM 7 0.0038
125 BILIARY COLIC 11 0.0038
126 BONE NEOPLASM 4 0.0037
127 STREPTOCOCCAL BACTERAEMIA 4 0.0037
128 INCISIONAL HERNIA 5 0.0036
129 ENTERITIS 23 0.0036
130 HEPATIC PAIN 15 0.0035
131 CACHEXIA 18 0.0035
132 KIDNEY FIBROSIS 6 0.0035
133 MUCOSAL HAEMORRHAGE 4 0.0034
134 HYPOPITUITARISM 6 0.0034
135 HYPOGLYCAEMIA 167 0.0034
136 HYPERVOLAEMIA 17 0.0034
137 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 185 0.0034
138 SUBILEUS 7 0.0034
139 ESCHERICHIA TEST POSITIVE 4 0.0033
140 HAEMATOMA MUSCLE 4 0.0033
141 STEROID DIABETES 5 0.0033
142 DIABETES INSIPIDUS 8 0.0033
143 DUODENITIS 10 0.0033
144 SMALL INTESTINAL OBSTRUCTION 40 0.0032
145 STOMA SITE HAEMORRHAGE 5 0.0032
146 RASH MORBILLIFORM 9 0.0032
147 CHOLECYSTITIS INFECTIVE 9 0.0032
148 GASTRIC ULCER PERFORATION 4 0.0032
149 HEPATIC MASS 6 0.0031
150 HYPOGLYCAEMIA NEONATAL 5 0.0031
151 BILIARY OBSTRUCTION 4 0.0031
152 ADRENOCORTICAL INSUFFICIENCY ACUTE 6 0.0031
153 PITUITARY TUMOUR BENIGN 5 0.0031
154 PRODUCT ADMINISTRATION INTERRUPTED 24 0.0031
155 DEVICE RELATED SEPSIS 6 0.0030
156 HEPATORENAL SYNDROME 5 0.0030
157 COLITIS MICROSCOPIC 14 0.0030
158 VOLVULUS 7 0.0030
159 SECOND PRIMARY MALIGNANCY 24 0.0029
160 BILE DUCT STONE 9 0.0028
161 AORTIC VALVE INCOMPETENCE 12 0.0028
162 LYMPHOCYTOSIS 6 0.0028
163 ERYSIPELAS 14 0.0028
164 PORTAL VEIN THROMBOSIS 9 0.0028
165 LYMPHOCYTE COUNT INCREASED 9 0.0028
166 BILIARY DILATATION 4 0.0027
167 BLOOD PRESSURE DIASTOLIC DECREASED 20 0.0027
168 RECURRENT CANCER 11 0.0027
169 FAILURE TO THRIVE 14 0.0027
170 METASTASES TO BONE 44 0.0027
171 METASTASIS 19 0.0027
172 VARICES OESOPHAGEAL 8 0.0026
173 BLOOD PRESSURE SYSTOLIC DECREASED 12 0.0026
174 STEATORRHOEA 7 0.0026
175 FUNCTIONAL GASTROINTESTINAL DISORDER 9 0.0026
176 DERMATITIS EXFOLIATIVE GENERALISED 9 0.0026
177 RESPIRATORY ACIDOSIS 10 0.0025
178 MALABSORPTION 13 0.0025
179 MALIGNANT NEOPLASM PROGRESSION 253 0.0025
180 HEPATIC ENCEPHALOPATHY 23 0.0025
181 VASCULAR DEVICE INFECTION 11 0.0024
182 ESCHERICHIA URINARY TRACT INFECTION 10 0.0024
183 CANCER PAIN 6 0.0023
184 INJECTION SITE OEDEMA 4 0.0023
185 BLOOD CHLORIDE INCREASED 4 0.0023
186 THERAPY NON-RESPONDER 104 0.0023
187 RETROPERITONEAL HAEMATOMA 5 0.0023
188 FAECES PALE 5 0.0022
189 NEOPLASM PROGRESSION 78 0.0022
190 BACTERIAL TEST POSITIVE 5 0.0022
191 X-RAY ABNORMAL 4 0.0022
192 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 16 0.0022
193 HAEMODYNAMIC INSTABILITY 17 0.0022
194 CHOLELITHIASIS 72 0.0022
195 NEOPLASM 25 0.0022
196 ENCEPHALITIS 15 0.0022
197 PHLEBITIS 11 0.0021
198 MALNUTRITION 24 0.0021
199 ASCITES 63 0.0021
200 HEART VALVE INCOMPETENCE 6 0.0021
201 METASTASES TO SPINE 7 0.0021
202 SINUS BRADYCARDIA 20 0.0021
203 ADENOVIRUS INFECTION 6 0.0021
204 HYPOGLYCAEMIC UNCONSCIOUSNESS 4 0.0020
205 INJECTION SITE ABSCESS 5 0.0020
206 ADHESION 3 0.0020
207 CARDIAC FAILURE ACUTE 13 0.0019
208 PORTAL HYPERTENSION 6 0.0019
209 NEUTROPENIC COLITIS 4 0.0019
210 INJECTION SITE HYPERSENSITIVITY 6 0.0019
211 WALKING DISABILITY 4 0.0019
212 UPPER GASTROINTESTINAL HAEMORRHAGE 32 0.0019
213 CARDIOMYOPATHY 28 0.0019
214 HYPOVOLAEMIA 11 0.0019
215 ABDOMINAL MASS 5 0.0019
216 HORMONE LEVEL ABNORMAL 9 0.0018
217 BACTERIAL SEPSIS 6 0.0018
218 NORMAL NEWBORN 10 0.0018
219 GRAFT VERSUS HOST DISEASE 13 0.0018
220 INTESTINAL OBSTRUCTION 68 0.0018
221 RESPIRATORY RATE INCREASED 16 0.0018
222 HYPERAMMONAEMIA 9 0.0018
223 BK VIRUS INFECTION 6 0.0018
224 METASTASES TO LYMPH NODES 12 0.0018
225 GENERALISED OEDEMA 22 0.0018
226 NEOPLASM RECURRENCE 6 0.0018
227 TRICUSPID VALVE INCOMPETENCE 14 0.0018
228 CARDIAC VALVE DISEASE 10 0.0017
229 LUMBAR VERTEBRAL FRACTURE 8 0.0017
230 BLOOD PRESSURE DIASTOLIC INCREASED 8 0.0017
231 DEFAECATION URGENCY 12 0.0017
232 BLOOD LACTIC ACID INCREASED 9 0.0017
233 JAUNDICE CHOLESTATIC 6 0.0017
234 GROWTH RETARDATION 5 0.0017
235 NEEDLE ISSUE 49 0.0017
236 TUMOUR MARKER INCREASED 8 0.0017
237 PREMATURE RUPTURE OF MEMBRANES 4 0.0017
238 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 10 0.0016
239 DIASTOLIC DYSFUNCTION 5 0.0016
240 ACCIDENTAL DEATH 3 0.0016
241 CHOLANGITIS 10 0.0016
242 AUTOIMMUNE HEPATITIS 11 0.0016
243 ILEOSTOMY 4 0.0016
244 ELECTROLYTE IMBALANCE 18 0.0015
245 FAECES HARD 6 0.0015
246 RHINOVIRUS INFECTION 6 0.0015
247 FLATULENCE 87 0.0015
248 URINE OUTPUT INCREASED 4 0.0015
249 HYPOCALCAEMIA 29 0.0015
250 BLOOD MAGNESIUM DECREASED 13 0.0015
251 COAGULOPATHY 25 0.0015
252 BREAST MASS 10 0.0015
253 HYPOPHOSPHATAEMIA 11 0.0015
254 THERAPY PARTIAL RESPONDER 23 0.0015
255 GOITRE 6 0.0015
256 EXTRAVASATION 6 0.0015
257 HYPERGLYCAEMIA 53 0.0015
258 VENTRICULAR TACHYCARDIA 24 0.0015
259 BOWEL MOVEMENT IRREGULARITY 11 0.0014
260 PROCTITIS 4 0.0014
261 HEPATIC FAILURE 43 0.0014
262 NEPHROPATHY TOXIC 16 0.0014
263 HEPATOMEGALY 14 0.0014
264 CLOSTRIDIUM DIFFICILE COLITIS 15 0.0014
265 MULTIPLE ORGAN DYSFUNCTION SYNDROME 40 0.0014
266 ABSCESS LIMB 6 0.0014
267 PANCREATIC CARCINOMA METASTATIC 4 0.0014
268 TUMOUR HAEMORRHAGE 4 0.0014
269 HYPOGLYCAEMIC COMA 4 0.0014
270 FLANK PAIN 13 0.0014
271 BONE LESION 5 0.0014
272 INJECTION SITE EXTRAVASATION 17 0.0014
273 DISEASE PROGRESSION 163 0.0014
274 MOTOR DYSFUNCTION 14 0.0014
275 IMMUNE-MEDIATED ENTEROCOLITIS 5 0.0014
276 RECTAL DISCHARGE 5 0.0014
277 BLOOD IRON DECREASED 16 0.0013
278 HYPERCHOLESTEROLAEMIA 13 0.0013
279 TERMINAL STATE 9 0.0013
280 BLOOD CALCIUM DECREASED 15 0.0013
281 FLUSHING 135 0.0013
282 CYTOMEGALOVIRUS INFECTION 22 0.0013
283 BLOOD THYROID STIMULATING HORMONE DECREASED 6 0.0013
284 EMBOLISM VENOUS 4 0.0013
285 MELAENA 29 0.0013
286 ACUTE HEPATIC FAILURE 18 0.0013
287 ANAL FISTULA 7 0.0013
288 ACIDOSIS 10 0.0013
289 COMPRESSION FRACTURE 7 0.0013
290 ISCHAEMIA 6 0.0013
291 PERICARDIAL EFFUSION 30 0.0013
292 OLIGURIA 8 0.0013
293 ANURIA 11 0.0013
294 BLOOD CREATININE DECREASED 4 0.0013
295 SKIN ABRASION 6 0.0013
296 BLADDER PAIN 4 0.0013
297 TUMOUR LYSIS SYNDROME 11 0.0012
298 INTESTINAL PERFORATION 14 0.0012
299 ACUTE PULMONARY OEDEMA 7 0.0012
300 ARTERIOSPASM CORONARY 5 0.0012
301 VITAMIN B12 DEFICIENCY 5 0.0012
302 DEVICE RELATED INFECTION 19 0.0012
303 GASTROINTESTINAL HAEMORRHAGE 103 0.0012
304 VITAMIN D DEFICIENCY 12 0.0012
305 THROMBOSIS IN DEVICE 4 0.0012
306 INJECTION SITE INFECTION 4 0.0012
307 METABOLIC DISORDER 7 0.0012
308 ATRIOVENTRICULAR BLOCK COMPLETE 8 0.0012
309 GLUCOSE TOLERANCE IMPAIRED 7 0.0012
310 ABDOMINAL INFECTION 3 0.0012
311 THYROID DISORDER 18 0.0012
312 HEPATITIS B 7 0.0012
313 ATRIOVENTRICULAR BLOCK FIRST DEGREE 5 0.0012
314 REBOUND EFFECT 13 0.0011
315 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
316 HEART RATE DECREASED 40 0.0011
317 ABDOMINAL ABSCESS 5 0.0011
318 METASTASES TO LUNG 13 0.0011
319 CYTOMEGALOVIRUS VIRAEMIA 5 0.0011
320 ILEUS PARALYTIC 5 0.0011
321 FRUSTRATION TOLERANCE DECREASED 9 0.0011
322 FACIAL BONES FRACTURE 4 0.0011
323 URINE ABNORMALITY 5 0.0011
324 EMBOLISM 9 0.0011
325 LOWER GASTROINTESTINAL HAEMORRHAGE 8 0.0011
326 HYPOMAGNESAEMIA 15 0.0011
327 PROTEIN TOTAL DECREASED 4 0.0011
328 HEPATIC NECROSIS 4 0.0011
329 ELECTROCARDIOGRAM QT PROLONGED 38 0.0011
330 ILEUS 13 0.0010
331 INJECTION SITE DISCOMFORT 11 0.0010
332 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
333 HYPOALBUMINAEMIA 8 0.0010
334 INJECTION SITE MASS 38 0.0010
335 VENOUS THROMBOSIS 4 0.0010
336 HYPOKALAEMIA 47 0.0010
337 PANCREATIC DISORDER 5 0.0010
338 PRODUCT PRESCRIBING ISSUE 22 0.0010
339 COLITIS 38 0.0010
340 PROTEINURIA 19 0.0010
341 BRADYCARDIA 53 0.0010
342 ABDOMINAL PAIN 232 0.0010
343 TOXIC SKIN ERUPTION 10 0.0010
344 PULMONARY TOXICITY 7 0.0010
345 KLEBSIELLA INFECTION 5 0.0010
346 ABDOMINAL DISTENSION 103 0.0010
347 DERMATITIS ACNEIFORM 6 0.0010
348 POST PROCEDURAL INFECTION 8 0.0010
349 PERIPHERAL ISCHAEMIA 4 0.0010
350 RESPIRATORY DEPRESSION 12 0.0010
351 BLOOD PRESSURE DECREASED 65 0.0010
352 CARDIOGENIC SHOCK 14 0.0010
353 HAEMORRHOIDS 19 0.0010
354 VARICOSE VEIN 5 0.0010
355 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
356 SEPTIC SHOCK 41 0.0009
357 ENCEPHALOPATHY 23 0.0009
358 GASTROINTESTINAL MOTILITY DISORDER 5 0.0009
359 PROCTALGIA 6 0.0009
360 BLOOD POTASSIUM DECREASED 28 0.0009
361 MASS 13 0.0009
362 METASTATIC NEOPLASM 4 0.0009
363 FREQUENT BOWEL MOVEMENTS 25 0.0009
364 ACUTE KIDNEY INJURY 141 0.0009
365 POLYP 6 0.0009
366 HYPOGAMMAGLOBULINAEMIA 6 0.0009
367 PULMONARY HYPERTENSION 19 0.0009
368 HOSPICE CARE 9 0.0009
369 MUSCULOSKELETAL CHEST PAIN 14 0.0009
370 BRONCHOPULMONARY ASPERGILLOSIS 7 0.0009
371 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 7 0.0009
372 STREPTOCOCCAL INFECTION 5 0.0009
373 SEPSIS 100 0.0009
374 DRUG RESISTANCE 23 0.0009
375 PULMONARY HAEMORRHAGE 7 0.0009
376 TORSADE DE POINTES 7 0.0009
377 IRON DEFICIENCY 4 0.0009
378 HYPOTHERMIA 9 0.0009
379 PLEURAL EFFUSION 54 0.0009
380 COLECTOMY 5 0.0009
381 CHOLECYSTITIS ACUTE 5 0.0009
382 BLOOD ALBUMIN DECREASED 7 0.0009
383 CHOLECYSTECTOMY 10 0.0009
384 EAR DISORDER 4 0.0009
385 URINARY RETENTION 29 0.0009
386 EXERCISE TOLERANCE DECREASED 5 0.0009
387 IRON DEFICIENCY ANAEMIA 8 0.0009
388 SYNOVIAL CYST 4 0.0009
389 ENTEROCOLITIS 5 0.0009
390 BLOOD PRESSURE INCREASED 132 0.0009
391 OFF LABEL USE 753 0.0009
392 OSTEOPENIA 13 0.0009
393 ABNORMAL FAECES 7 0.0009
394 DISSEMINATED INTRAVASCULAR COAGULATION 12 0.0009
395 DIARRHOEA 550 0.0009
396 HEPATIC CIRRHOSIS 16 0.0009
397 DUODENAL ULCER 6 0.0008
398 BACTERAEMIA 10 0.0008
399 CHOLECYSTITIS 10 0.0008
400 SLEEP APNOEA SYNDROME 16 0.0008
401 CHOLESTASIS 16 0.0008
402 VISUAL FIELD DEFECT 6 0.0008
403 LEUKOCYTOSIS 15 0.0008
404 HAEMATEMESIS 21 0.0008
405 ENTEROCOCCAL INFECTION 4 0.0008
406 DIZZINESS POSTURAL 8 0.0008
407 HYPOXIA 29 0.0008
408 THROMBOCYTOPENIA 92 0.0008
409 GASTROENTERITIS 12 0.0008
410 QUALITY OF LIFE DECREASED 11 0.0008
411 CYTOPENIA 10 0.0008
412 BLOOD BILIRUBIN INCREASED 22 0.0008
413 AMYLASE INCREASED 3 0.0008
414 HAEMATOMA 21 0.0008
415 MYOPATHY 7 0.0008
416 BLOOD ALKALINE PHOSPHATASE INCREASED 20 0.0008
417 HYDRONEPHROSIS 6 0.0008
418 FLUID INTAKE REDUCED 4 0.0008
419 EATING DISORDER 17 0.0008
420 HEPATIC CYTOLYSIS 10 0.0008
421 GALLBLADDER DISORDER 14 0.0008
422 METABOLIC ACIDOSIS 25 0.0008
423 HAEMATOCHEZIA 43 0.0008
424 CLOSTRIDIUM DIFFICILE INFECTION 17 0.0008
425 ANAL INCONTINENCE 7 0.0008
426 RIB FRACTURE 16 0.0008
427 CARDIAC ARREST 64 0.0008
428 STOMATITIS 47 0.0008
429 TREATMENT FAILURE 64 0.0008
430 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 18 0.0008
431 EJECTION FRACTION DECREASED 12 0.0008
432 GASTROINTESTINAL CARCINOMA 7 0.0008
433 HYPERKALAEMIA 27 0.0008
434 RENAL PAIN 8 0.0008
435 HEART RATE IRREGULAR 17 0.0008
436 PANCYTOPENIA 42 0.0008
437 ABDOMINAL PAIN LOWER 19 0.0008
438 DIARRHOEA HAEMORRHAGIC 7 0.0007
439 FOOD POISONING 4 0.0007
440 ADRENAL INSUFFICIENCY 9 0.0007
441 POSTOPERATIVE WOUND INFECTION 5 0.0007
442 SPUTUM DISCOLOURED 7 0.0007
443 GENERAL PHYSICAL CONDITION ABNORMAL 5 0.0007
444 PRODUCT PACKAGING ISSUE 7 0.0007
445 INTERNATIONAL NORMALISED RATIO INCREASED 21 0.0007
446 SKIN LACERATION 8 0.0007
447 TACHYPNOEA 10 0.0007
448 PALLOR 20 0.0007
449 DEHYDRATION 98 0.0007
450 PNEUMONITIS 20 0.0007
451 PRODUCTIVE COUGH 35 0.0007
452 POLYURIA 6 0.0007
453 GLOMERULAR FILTRATION RATE DECREASED 9 0.0007
454 ASPIRATION 8 0.0007
455 GASTROINTESTINAL PAIN 8 0.0007
456 MUCOSAL INFLAMMATION 19 0.0007
457 HYPERKERATOSIS 4 0.0007
458 LYMPHOEDEMA 5 0.0007
459 PRODUCT USE IN UNAPPROVED INDICATION 179 0.0007
460 HAEMOPTYSIS 20 0.0007
461 KIDNEY INFECTION 14 0.0007
462 BLOOD GLUCOSE DECREASED 34 0.0007
463 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 18 0.0007
464 METASTASES TO CENTRAL NERVOUS SYSTEM 9 0.0007
465 MULTI-ORGAN FAILURE 12 0.0007
466 MUSCLE STRAIN 6 0.0007
467 DECREASED APPETITE 161 0.0007
468 RALES 4 0.0007
469 HYPERTRIGLYCERIDAEMIA 4 0.0007
470 GENERAL PHYSICAL HEALTH DETERIORATION 79 0.0007
471 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
472 RENAL IMPAIRMENT 57 0.0007
473 ENERGY INCREASED 4 0.0007
474 NEPHROLITHIASIS 31 0.0007
475 HYPERBILIRUBINAEMIA 7 0.0007
476 HERNIA 13 0.0007
477 RESPIRATORY FAILURE 49 0.0007
478 PETECHIAE 7 0.0007
479 WEIGHT DECREASED 187 0.0007
480 GASTROINTESTINAL INFECTION 6 0.0007
481 PANCREATITIS ACUTE 15 0.0007
482 RENAL DISORDER 31 0.0007
483 RED BLOOD CELL COUNT DECREASED 19 0.0007
484 DYSPNOEA EXERTIONAL 25 0.0007
485 THERAPEUTIC RESPONSE DECREASED 40 0.0007
486 LIVER DISORDER 29 0.0007
487 BRAIN NEOPLASM 6 0.0007
488 HOSPITALISATION 100 0.0007
489 FEBRILE NEUTROPENIA 43 0.0006
490 CONCOMITANT DISEASE AGGRAVATED 4 0.0006
491 FAECES DISCOLOURED 14 0.0006
492 PRODUCT USE ISSUE 121 0.0006
493 NEPHROPATHY 6 0.0006
494 MUSCULOSKELETAL DISCOMFORT 11 0.0006
495 BLOOD GLUCOSE FLUCTUATION 7 0.0006
496 NASAL DRYNESS 4 0.0006
497 BODY TEMPERATURE INCREASED 13 0.0006
498 HAEMOGLOBIN DECREASED 65 0.0006
499 OEDEMA PERIPHERAL 77 0.0006
500 PREMATURE BABY 19 0.0006
501 PNEUMOTHORAX 10 0.0006
502 HEPATOTOXICITY 14 0.0006
503 SCIATICA 10 0.0006
504 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
505 COLD SWEAT 11 0.0006
506 HYPERTENSION 132 0.0006
507 HYPERTHYROIDISM 9 0.0006
508 ATELECTASIS 6 0.0006
509 ANGINA UNSTABLE 4 0.0006
510 SCAB 7 0.0006
511 INTERNAL HAEMORRHAGE 7 0.0006
512 DRUG INTERACTION 97 0.0006
513 THERAPY CHANGE 6 0.0006
514 DISEASE RECURRENCE 29 0.0006
515 ASPERGILLUS INFECTION 4 0.0006
516 GASTRIC HAEMORRHAGE 7 0.0006
517 HYPOTENSION 122 0.0006
518 TOOTH INFECTION 8 0.0006
519 PULMONARY CONGESTION 8 0.0006
520 LIVER FUNCTION TEST INCREASED 13 0.0006
521 CONTUSION 58 0.0006
522 CARDIAC FAILURE 48 0.0006
523 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
524 SPINAL PAIN 7 0.0006
525 BLOOD GLUCOSE ABNORMAL 11 0.0006
526 CONTRAINDICATED PRODUCT ADMINISTERED 18 0.0006
527 TYPE 2 DIABETES MELLITUS 20 0.0006
528 DRUG INTOLERANCE 57 0.0006
529 PANCREATITIS 31 0.0006
530 VITAMIN D DECREASED 5 0.0006
531 EAR DISCOMFORT 6 0.0006
532 NEPHROTIC SYNDROME 4 0.0006
533 PSEUDOMONAS INFECTION 5 0.0006
534 VENTRICULAR EXTRASYSTOLES 6 0.0006
535 ANAEMIA 110 0.0006
536 NOCTURIA 7 0.0006
537 TENDERNESS 6 0.0006
538 LOWER RESPIRATORY TRACT INFECTION 26 0.0006
539 SYRINGE ISSUE 10 0.0006
540 GROIN PAIN 5 0.0006
541 CARDIOMEGALY 7 0.0006
542 HYPERCALCAEMIA 7 0.0006
543 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 102 0.0006
544 BLOOD TRIGLYCERIDES INCREASED 10 0.0006
545 LYMPHOCYTE COUNT DECREASED 10 0.0006
546 HEPATOCELLULAR INJURY 8 0.0006
547 HAIR COLOUR CHANGES 7 0.0006
548 PRODUCT SUPPLY ISSUE 4 0.0006
549 GOUT 10 0.0006
550 DIABETES MELLITUS 42 0.0006
551 FLUID OVERLOAD 8 0.0005
552 SYNCOPE 55 0.0005
553 DYSSTASIA 16 0.0005
554 DELIRIUM 19 0.0005
555 DRUG INEFFECTIVE 718 0.0005
556 ABDOMINAL PAIN UPPER 112 0.0005
557 INFLAMMATION 28 0.0005
558 UNRESPONSIVE TO STIMULI 14 0.0005
559 OVARIAN CANCER 5 0.0005
560 COLON CANCER 8 0.0005
561 BACTERIAL INFECTION 10 0.0005
562 OEDEMA 29 0.0005
563 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 38 0.0005
564 CANDIDA INFECTION 9 0.0005
565 CONSTIPATION 116 0.0005
566 THERAPY INTERRUPTED 38 0.0005
567 BLOOD SODIUM DECREASED 10 0.0005
568 LEUKAEMIA 5 0.0005
569 CIRCULATORY COLLAPSE 9 0.0005
570 MYOCARDIAL ISCHAEMIA 6 0.0005
571 BLOOD URINE PRESENT 10 0.0005
572 ILL-DEFINED DISORDER 32 0.0005
573 HEPATOCELLULAR CARCINOMA 4 0.0005
574 HAEMATURIA 18 0.0005
575 MICTURITION URGENCY 6 0.0005
576 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 5 0.0005
577 EPILEPSY 16 0.0005
578 SHOCK 12 0.0005
579 ERUCTATION 10 0.0005
580 APNOEA 4 0.0005
581 GASTROINTESTINAL DISORDER 46 0.0005
582 HAEMORRHAGIC STROKE 4 0.0005
583 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 15 0.0005
584 GASTROINTESTINAL INFLAMMATION 4 0.0005
585 INJECTION SITE SWELLING 39 0.0005
586 GAIT INABILITY 17 0.0005
587 PLATELET COUNT DECREASED 54 0.0005
588 HAEMATOCRIT DECREASED 10 0.0005
589 RHABDOMYOLYSIS 21 0.0005
590 LOW BIRTH WEIGHT BABY 4 0.0005
591 CYTOKINE RELEASE SYNDROME 10 0.0005
592 PELVIC PAIN 9 0.0005
593 BONE PAIN 29 0.0005
594 PRODUCT ADMINISTRATION ERROR 10 0.0005
595 BURSITIS 6 0.0005
596 PRESYNCOPE 12 0.0005
597 TASTE DISORDER 10 0.0005
598 DECUBITUS ULCER 4 0.0005
599 RECTAL HAEMORRHAGE 21 0.0005
600 HYPERAESTHESIA 4 0.0005
601 LETHARGY 28 0.0005
602 TACHYCARDIA 43 0.0005
603 MYELODYSPLASTIC SYNDROME 7 0.0005
604 JAUNDICE 13 0.0005
605 HYPERHIDROSIS 62 0.0005
606 CONDITION AGGRAVATED 146 0.0005
607 SENSATION OF FOREIGN BODY 4 0.0005
608 SKIN PLAQUE 4 0.0005
609 INCONTINENCE 5 0.0005
610 FULL BLOOD COUNT ABNORMAL 5 0.0005
611 OSTEOARTHRITIS 20 0.0005
612 NAUSEA 373 0.0005
613 POST PROCEDURAL COMPLICATION 9 0.0005
614 MENTAL STATUS CHANGES 13 0.0005
615 FEELING COLD 13 0.0005
616 VOMITING 219 0.0005
617 CARDIAC OPERATION 4 0.0005
618 WOUND 13 0.0005
619 CARDIAC MURMUR 4 0.0005
620 ALTERED STATE OF CONSCIOUSNESS 10 0.0005
621 ORTHOSTATIC HYPOTENSION 8 0.0005
622 URINE OUTPUT DECREASED 4 0.0005
623 WOUND INFECTION 5 0.0005
624 DEATH 393 0.0005
625 BLOOD CALCIUM INCREASED 4 0.0005
626 HEPATIC ENZYME INCREASED 31 0.0005
627 STAPHYLOCOCCAL INFECTION 15 0.0005
628 EPISTAXIS 34 0.0005
629 LUNG INFILTRATION 4 0.0005
630 BLOOD PRESSURE ABNORMAL 9 0.0005
631 PULMONARY EMBOLISM 43 0.0005
632 INJECTION SITE HAEMORRHAGE 36 0.0005
633 HAEMORRHAGE 47 0.0004
634 RASH MACULO-PAPULAR 10 0.0004
635 ASTHENIA 169 0.0004
636 DRUG-INDUCED LIVER INJURY 14 0.0004
637 URINARY TRACT INFECTION 76 0.0004
638 FISTULA 5 0.0004
639 ABNORMAL LOSS OF WEIGHT 3 0.0004
640 MOOD ALTERED 12 0.0004
641 PREMATURE DELIVERY 7 0.0004
642 OBESITY 7 0.0004
643 HYPOTHYROIDISM 14 0.0004
644 INJECTION SITE WARMTH 9 0.0004
645 LOSS OF CONSCIOUSNESS 56 0.0004
646 PERIPHERAL COLDNESS 6 0.0004
647 ILLNESS 45 0.0004
648 RENAL FAILURE 58 0.0004
649 RESPIRATORY DISTRESS 12 0.0004
650 PRODUCT SUBSTITUTION ISSUE 25 0.0004
651 FLUID RETENTION 22 0.0004
652 SQUAMOUS CELL CARCINOMA 4 0.0004
653 SINUS TACHYCARDIA 6 0.0004
654 RETCHING 9 0.0004
655 HAEMATOTOXICITY 4 0.0004
656 PYREXIA 145 0.0004
657 BLOOD UREA INCREASED 7 0.0004
658 FATIGUE 325 0.0004
659 PANCREATIC CARCINOMA 12 0.0004
660 LOCALISED INFECTION 10 0.0004
661 HYPOKINESIA 6 0.0004
662 C-REACTIVE PROTEIN INCREASED 15 0.0004
663 NO THERAPEUTIC RESPONSE 5 0.0004
664 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 29 0.0004
665 DYSURIA 15 0.0004
666 LIMB INJURY 11 0.0004
667 HIP FRACTURE 13 0.0004
668 PULMONARY MASS 6 0.0004
669 TREATMENT NONCOMPLIANCE 22 0.0004
670 BRAIN INJURY 4 0.0004
671 DIVERTICULITIS 11 0.0004
672 PROCEDURAL PAIN 11 0.0004
673 EMPHYSEMA 4 0.0004
674 BRAIN OEDEMA 5 0.0004
675 INJECTION SITE PAIN 121 0.0004
676 INSURANCE ISSUE 6 0.0004
677 THIRST 7 0.0004
678 HIP ARTHROPLASTY 6 0.0004
679 NEUTROPHIL COUNT INCREASED 4 0.0004
680 PERIPHERAL SWELLING 60 0.0004
681 OSTEOPOROSIS 16 0.0004
682 OROPHARYNGEAL PAIN 36 0.0004
683 LYMPHOMA 6 0.0004
684 PRODUCT DOSE OMISSION ISSUE 114 0.0004
685 INJECTION SITE INDURATION 5 0.0004
686 CHILLS 45 0.0004
687 HYPERSOMNIA 11 0.0004
688 TRANSFUSION 4 0.0004
689 MUSCULOSKELETAL PAIN 20 0.0004
690 CYANOSIS 6 0.0004
691 INCORRECT PRODUCT STORAGE 5 0.0004
692 POOR QUALITY PRODUCT ADMINISTERED 4 0.0004
693 LIVER FUNCTION TEST ABNORMAL 11 0.0004
694 ULCER 6 0.0004
695 DISCOMFORT 23 0.0004
696 FALL 125 0.0004
697 NEUTROPENIA 51 0.0004
698 JOINT INJURY 8 0.0004
699 BODY HEIGHT DECREASED 4 0.0004
700 OXYGEN SATURATION DECREASED 21 0.0004
701 MALIGNANT MELANOMA 5 0.0004
702 HYPONATRAEMIA 21 0.0004
703 THERAPY CESSATION 19 0.0004
704 DEEP VEIN THROMBOSIS 24 0.0004
705 BLOOD CREATININE INCREASED 24 0.0004
706 LYMPHADENOPATHY 13 0.0004
707 IMPAIRED GASTRIC EMPTYING 5 0.0004
708 ABDOMINAL DISCOMFORT 61 0.0004
709 SEIZURE 42 0.0004
710 INJECTION SITE NODULE 4 0.0004
711 DRUG LEVEL INCREASED 6 0.0004
712 TRANSAMINASES INCREASED 8 0.0004
713 RASH PAPULAR 8 0.0004
714 MALAISE 155 0.0004
715 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
716 BACK PAIN 82 0.0004
717 SCAR 6 0.0004
718 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
719 PARALYSIS 5 0.0003
720 CHEST PAIN 64 0.0003
721 CYSTITIS 11 0.0003
722 BONE MARROW FAILURE 7 0.0003
723 POST PROCEDURAL HAEMORRHAGE 4 0.0003
724 NEUROTOXICITY 6 0.0003
725 CHEST DISCOMFORT 35 0.0003
726 URINARY INCONTINENCE 10 0.0003
727 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
728 COMA 16 0.0003
729 MYOCLONUS 4 0.0003
730 ACCIDENT 4 0.0003
731 MYELOSUPPRESSION 12 0.0003
732 HEART RATE INCREASED 33 0.0003
733 MOUTH ULCERATION 7 0.0003
734 FOETAL EXPOSURE DURING PREGNANCY 27 0.0003
735 RESTLESS LEGS SYNDROME 6 0.0003
736 DYSPNOEA 186 0.0003
737 LIVER INJURY 8 0.0003
738 NERVOUSNESS 17 0.0003
739 DYSPEPSIA 32 0.0003
740 RHINORRHOEA 21 0.0003
741 PNEUMONIA 105 0.0003
742 GAIT DISTURBANCE 62 0.0003
743 NASAL CONGESTION 19 0.0003
744 LIMB DISCOMFORT 10 0.0003
745 DEMENTIA 9 0.0003
746 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
747 MUSCLE ATROPHY 4 0.0003
748 INTENTIONAL DOSE OMISSION 9 0.0003
749 INCREASED APPETITE 6 0.0003
750 ABSCESS 5 0.0003
751 PULMONARY OEDEMA 14 0.0003
752 SEROTONIN SYNDROME 6 0.0003
753 LOWER LIMB FRACTURE 6 0.0003
754 AFFECT LABILITY 3 0.0003
755 INFECTION 45 0.0003
756 CHROMATURIA 7 0.0003
757 MUSCLE TIGHTNESS 5 0.0003
758 ATRIAL FIBRILLATION 30 0.0003
759 BLOOD POTASSIUM INCREASED 5 0.0003
760 CEREBRAL HAEMORRHAGE 11 0.0003
761 SKIN FISSURES 6 0.0003
762 JOINT SWELLING 37 0.0003
763 RENAL FAILURE ACUTE 13 0.0003
764 HOT FLUSH 23 0.0003
765 DIZZINESS 152 0.0003
766 BEDRIDDEN 4 0.0003
767 SARS-COV-2 TEST POSITIVE 4 0.0003
768 DRUG EFFECT INCOMPLETE 11 0.0003
769 CRYING 11 0.0003
770 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
771 UPPER LIMB FRACTURE 6 0.0003
772 RESPIRATORY DISORDER 9 0.0003
773 NEOPLASM MALIGNANT 20 0.0003
774 SPINAL FRACTURE 6 0.0003
775 PAIN IN EXTREMITY 88 0.0003
776 LACRIMATION INCREASED 9 0.0003
777 FULL BLOOD COUNT DECREASED 6 0.0003
778 PRODUCT PHYSICAL ISSUE 6 0.0003
779 CORONARY ARTERY DISEASE 9 0.0003
780 FEEDING DISORDER 6 0.0003
781 HEPATIC FUNCTION ABNORMAL 11 0.0003
782 ALANINE AMINOTRANSFERASE INCREASED 18 0.0003
783 PAIN 180 0.0003
784 GINGIVAL BLEEDING 4 0.0003
785 DYSARTHRIA 11 0.0003
786 SWELLING FACE 19 0.0003
787 BLOOD PRESSURE FLUCTUATION 7 0.0003
788 PERITONITIS 6 0.0003
789 POLLAKIURIA 12 0.0003
790 APHONIA 4 0.0003
791 EOSINOPHILIA 5 0.0003
792 CONFUSIONAL STATE 46 0.0003
793 NEUROPATHY PERIPHERAL 27 0.0003
794 LYMPHOPENIA 4 0.0003
795 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
796 DYSGEUSIA 21 0.0003
797 DRUG ERUPTION 5 0.0003
798 MATERNAL EXPOSURE DURING PREGNANCY 25 0.0003
799 PNEUMONIA ASPIRATION 7 0.0003
800 ANGINA PECTORIS 8 0.0003
801 FEELING HOT 17 0.0003
802 CHRONIC KIDNEY DISEASE 21 0.0003
803 BLOOD GLUCOSE INCREASED 52 0.0003
804 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
805 APATHY 4 0.0003
806 HYPOPHAGIA 7 0.0003
807 WEIGHT INCREASED 61 0.0003
808 NASOPHARYNGITIS 50 0.0003
809 VIRAL INFECTION 9 0.0003
810 LIP SWELLING 9 0.0003
811 SKIN HAEMORRHAGE 4 0.0003
812 HEPATIC STEATOSIS 5 0.0003
813 SOMNOLENCE 54 0.0003
814 ORAL PAIN 6 0.0003
815 COUGH 75 0.0003
816 SPEECH DISORDER 14 0.0003
817 MUSCLE SPASMS 49 0.0003
818 HEADACHE 166 0.0003
819 HERPES ZOSTER 15 0.0003
820 THROMBOSIS 21 0.0003
821 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
822 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
823 DRY MOUTH 21 0.0003
824 BRAIN FOG 4 0.0003
825 TOXICITY TO VARIOUS AGENTS 43 0.0003
826 DEPRESSED LEVEL OF CONSCIOUSNESS 10 0.0003
827 DISORIENTATION 10 0.0003
828 HEPATIC CANCER 6 0.0002
829 MOVEMENT DISORDER 8 0.0002
830 PALPITATIONS 29 0.0002
831 LACTIC ACIDOSIS 8 0.0002
832 SWELLING 23 0.0002
833 ADVERSE DRUG REACTION 22 0.0002
834 OSTEONECROSIS 8 0.0002
835 OSTEONECROSIS OF JAW 6 0.0002
836 SLEEP DISORDER 17 0.0002
837 WHITE BLOOD CELL COUNT DECREASED 26 0.0002
838 CARDIO-RESPIRATORY ARREST 10 0.0002
839 CELLULITIS 12 0.0002
840 LABORATORY TEST ABNORMAL 7 0.0002
841 HEMIPARESIS 4 0.0002
842 MYOCARDIAL INFARCTION 41 0.0002
843 ALOPECIA 46 0.0002
844 ERYTHEMA 48 0.0002
845 GASTRIC DISORDER 8 0.0002
846 ARRHYTHMIA 11 0.0002
847 ARTHRALGIA 95 0.0002
848 HEAD DISCOMFORT 4 0.0002
849 GASTROOESOPHAGEAL REFLUX DISEASE 18 0.0002
850 SNEEZING 5 0.0002
851 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
852 SURGERY 13 0.0002
853 GASTROENTERITIS VIRAL 4 0.0002
854 ANXIETY 63 0.0002
855 MUSCULAR WEAKNESS 25 0.0002
856 PRODUCT AVAILABILITY ISSUE 5 0.0002
857 BONE DISORDER 4 0.0002
858 SKIN LESION 6 0.0002
859 AGITATION 16 0.0002
860 SKIN DISCOLOURATION 10 0.0002
861 ARTHROPATHY 12 0.0002
862 HYPOAESTHESIA 32 0.0002
863 ASTHMA 24 0.0002
864 VISUAL ACUITY REDUCED 7 0.0002
865 FUNGAL INFECTION 7 0.0002
866 RASH ERYTHEMATOUS 10 0.0002
867 MOBILITY DECREASED 15 0.0002
868 DIABETIC KETOACIDOSIS 5 0.0002
869 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
870 MENTAL DISORDER 9 0.0002
871 INTENTIONAL PRODUCT USE ISSUE 18 0.0002
872 ORAL HERPES 4 0.0002
873 ARTHRITIS 16 0.0002
874 WHEEZING 12 0.0002
875 FEELING ABNORMAL 48 0.0002
876 LEUKOPENIA 10 0.0002
877 ANAPHYLACTIC REACTION 11 0.0002
878 APHASIA 6 0.0002
879 CARDIOVASCULAR DISORDER 5 0.0002
880 VERTIGO 12 0.0002
881 NEUTROPHIL COUNT DECREASED 8 0.0002
882 TINNITUS 9 0.0002
883 BLISTER 11 0.0002
884 HEPATITIS 5 0.0002
885 ACUTE MYELOID LEUKAEMIA 3 0.0002
886 GASTRITIS 5 0.0002
887 DEPRESSED MOOD 10 0.0002
888 INFLUENZA 21 0.0002
889 EAR INFECTION 5 0.0002
890 CARDIAC FAILURE CONGESTIVE 15 0.0002
891 IRRITABLE BOWEL SYNDROME 4 0.0002
892 NIGHT SWEATS 6 0.0002
893 POOR QUALITY SLEEP 4 0.0002
894 VISUAL IMPAIRMENT 23 0.0002
895 MYALGIA 31 0.0002
896 NECK PAIN 10 0.0002
897 GLOSSODYNIA 4 0.0002
898 EYE PRURITUS 6 0.0002
899 UNDERDOSE 13 0.0002
900 EXPOSURE DURING PREGNANCY 11 0.0002
901 PAIN IN JAW 5 0.0002
902 INCORRECT DOSE ADMINISTERED 40 0.0002
903 TREMOR 29 0.0002
904 BALANCE DISORDER 15 0.0002
905 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
906 DYSKINESIA 7 0.0002
907 CARDIAC DISORDER 16 0.0002
908 DYSPHONIA 10 0.0002
909 LUNG NEOPLASM MALIGNANT 7 0.0002
910 ACUTE MYOCARDIAL INFARCTION 5 0.0002
911 PSYCHOTIC DISORDER 5 0.0002
912 PRODUCT DOSE OMISSION 11 0.0002
913 COVID-19 29 0.0002
914 CEREBROVASCULAR ACCIDENT 28 0.0002
915 PARAESTHESIA 26 0.0002
916 INTERSTITIAL LUNG DISEASE 8 0.0002
917 CEREBRAL INFARCTION 4 0.0002
918 LUNG DISORDER 8 0.0002
919 INJECTION SITE URTICARIA 4 0.0002
920 INJECTION SITE BRUISING 13 0.0002
921 BURNING SENSATION 11 0.0002
922 COLITIS ULCERATIVE 7 0.0002
923 ACUTE RESPIRATORY FAILURE 3 0.0002
924 ERECTILE DYSFUNCTION 4 0.0002
925 SKIN ULCER 4 0.0002
926 INJECTION SITE ERYTHEMA 19 0.0002
927 ECZEMA 8 0.0002
928 ADVERSE EVENT 14 0.0002
929 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
930 INSOMNIA 40 0.0002
931 EMOTIONAL DISTRESS 18 0.0001
932 MIGRAINE 14 0.0001
933 UNEVALUABLE EVENT 11 0.0001
934 INJECTION SITE REACTION 10 0.0001
935 RASH 63 0.0001
936 DEPRESSION 32 0.0001
937 VAGINAL HAEMORRHAGE 6 0.0001
938 PRURITUS 53 0.0001
939 DYSPHAGIA 13 0.0001
940 RESTLESSNESS 5 0.0001
941 CATARACT 8 0.0001
942 SKIN EXFOLIATION 11 0.0001
943 EMOTIONAL DISORDER 4 0.0001
944 HYPERSENSITIVITY 24 0.0001
945 RASH PRURITIC 7 0.0001
946 COGNITIVE DISORDER 6 0.0001
947 HEAD INJURY 4 0.0001
948 RENAL CANCER 6 0.0001
949 VISION BLURRED 17 0.0001
950 MEMORY IMPAIRMENT 17 0.0001
951 AMNESIA 8 0.0001
952 IMPAIRED HEALING 4 0.0001
953 EYE DISORDER 4 0.0001
954 INFLUENZA LIKE ILLNESS 10 0.0001
955 NO ADVERSE EVENT 22 0.0001
956 AGEUSIA 3 0.0001
957 SKIN DISORDER 4 0.0001
958 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
959 SINUSITIS 12 0.0001
960 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
961 SKIN IRRITATION 5 0.0001
962 BRONCHITIS 8 0.0001
963 EYE SWELLING 4 0.0001
964 URTICARIA 18 0.0001
965 BLOOD CHOLESTEROL INCREASED 5 0.0001
966 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
967 INTENTIONAL PRODUCT MISUSE 9 0.0001
968 MUSCULOSKELETAL STIFFNESS 9 0.0001
969 IRRITABILITY 6 0.0001
970 BREAST CANCER 9 0.0001
971 HYPOACUSIS 4 0.0001
972 PRODUCT STORAGE ERROR 8 0.0001
973 INJECTION SITE PRURITUS 6 0.0001
974 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
975 OCULAR HYPERAEMIA 4 0.0001
976 DRY SKIN 11 0.0001
977 PRODUCT QUALITY ISSUE 11 0.0001
978 DRUG DEPENDENCE 13 0.0001
979 ACNE 6 0.0001
980 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 16 0.0001
981 PROSTATE CANCER 6 0.0001
982 DRUG EFFECT DECREASED 4 0.0001
983 DRUG DOSE OMISSION 12 0.0001
984 MEDICATION ERROR 4 0.0001
985 HALLUCINATION 5 0.0001
986 INTENTIONAL OVERDOSE 4 0.0001
987 INFUSION RELATED REACTION 4 0.0001
988 SUICIDAL IDEATION 5 0.0001
989 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
990 DRUG WITHDRAWAL SYNDROME 4 0.0000
991 RHEUMATOID ARTHRITIS 5 0.0000
992 OVERDOSE 8 0.0000
993 PSORIASIS 4 0.0000